Published: 24 December 2019
Author(s): A.J. Manolis, M.S. Kallistratos, L.Ε. Poulimenos, G. Ambrosio, R. Dechend, J. Lopez-Sendon, G. Rosano, P. Collins
Issue: January 2020
Section: Review Article

The ESC CCS 2019 guidelines recognize that successful management of anginal symptoms relies on effective therapy tailored to individual patient characteristics but do not provide any specific advice or clarity on how to utilize pharmacotherapy in order to achieve these goals. In this review, we are going to summarize and discuss the main points of disagreement.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.